Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases.

Saved in:
Bibliographic Details
Title: Study Protocol: Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Metastases.
Authors: Robella M; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy., Berchialla P; Department of Clinical and Biological Sciences, University of Turin, 10124 Turin, Italy., Borsano A; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy., Cinquegrana A; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy., Ilari Civit A; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy., De Simone M; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy., Vaira M; Unit of Surgical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, 10060 Candiolo, Italy.
Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2021 May 25; Vol. 18 (11). Date of Electronic Publication: 2021 May 25.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1660-4601
DOI:10.3390/ijerph18115656